QuidelOrtho Receives Health Canada Approval For Quidel Triage PLGF Test For Laboratory Use In Canada
Portfolio Pulse from Benzinga Newsdesk
QuidelOrtho has received Health Canada approval for its Quidel Triage PLGF test, designed for laboratory use in Canada. This approval marks a significant milestone for the company, allowing it to expand its product offerings in the Canadian healthcare market.
March 06, 2024 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
QuidelOrtho's Health Canada approval for its Quidel Triage PLGF test is likely to positively impact its market presence and revenue in Canada.
The approval of the Quidel Triage PLGF test by Health Canada is a significant regulatory milestone for QuidelOrtho, enabling the company to offer this product in the Canadian market. This expansion is likely to increase the company's revenue streams in Canada and enhance its market presence, given the importance of regulatory approvals in the healthcare sector for product distribution and adoption.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90